EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SLC44A2 regulates vascular smooth muscle cell phenotypic switching and aortic aneurysm

Tianyu Song, Shuang Zhao, Shanshan Luo, Chuansheng Chen, Xingeng Liu, Xiaoqi Wu, Zhongxu Sun, Jiawei Cao, Ziyu Wang, Yineng Wang, Bo Yu, Zhiren Zhang und 11 weitere

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci173690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Tianyu Song und 22 weiteren Autor:innen. Beteiligte Einrichtung: Gusu School, Nanjing Medical University, Suzhou, China. Hauptthemen laut MEDLINE: Aortic Aneurysm, Abdominal, Membrane Transport Proteins, Muscle, Smooth, Vascular, Myocytes, Smooth Muscle. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, the National Natural Science Foundation of China, the Young Elite Scientists Sponsorship Program by China Association for Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aortic aneurysm is a life-threatening disease with limited interventions that is closely related to vascular smooth muscle cell (VSMC) phenotypic switching. SLC44A2, a member of the solute carrier series 44 (SLC44) family, remains undercharacterized in the context of cardiovascular diseases. Venn diagram analysis based on microarray and single-cell RNA sequencing identified SLC44A2 as a major regulator of VSMC phenotypic switching in aortic aneurysm. Screening for Slc44a2 among aortic cell lineages demonstrated its predominant location in VSMCs. Elevated levels of SLC44A2 were evident in the aorta of both patients with abdominal aortic aneurysm and angiotensin II–infused (Ang II–infused) Apoe –/– mice. In vitro, SLC44A2 silencing promoted VSMCs toward a synthetic phenotype, while SLC44A2 overexpression attenuated VSMC phenotypic switching. VSMC-specific SLC44A2-knockout mice were more susceptible to aortic aneurysm under Ang II infusion, while SLC44A2 overexpression showed protective effects. Mechanistically, SLC44A2’s interaction with NRP1 and ITGB3 activates TGF-β/SMAD signaling, thereby promoting contractile gene expression. Elevated SLC44A2 in aortic aneurysm is associated with upregulated runt-related transcription factor 1 (RUNX1). Furthermore, low-dose lenalidomide (LEN; 20 mg/kg/day) suppressed aortic aneurysm progression by enhancing SLC44A2 expression. These findings reveal that the SLC44A2-NRP1-ITGB3 complex is a major regulator of VSMC phenotypic switching and provide a potential therapeutic approach (LEN) for aortic aneurysm treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Aneurysm, AbdominalMembrane Transport ProteinsMuscle, Smooth, VascularMyocytes, Smooth MuscleMembrane GlycoproteinsAnimalsHumansMaleMiceAngiotensin IIAortic AneurysmMice, KnockoutMice, Knockout, ApoEPhenotypeSignal Transduction

Stichwörter der Autor:innen

Cardiovascular diseaseSignal transductionVascular biology

Substanzen

Angiotensin IIMembrane Transport ProteinsSLC44A2 protein, humanMembrane Glycoproteins

Autor:innen und Institutionen

  • Gusu School, Nanjing Medical University, Suzhou, China.
  • Key Laboratory of Cardiovascular and Cerebrovascular Medicine, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjin…
  • State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), and.
  • Department of Cardiology, Central Laboratory, The First Affiliated Hospital of Harbin Medical University, NHC Key Laboratory of Cell Transplantation, Harbin Medical University, China.
  • Department of Vascular Surgery, The Affiliated Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
  • Department of Urology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Förderung

  • the National Key Research and Development Program of China
  • the National Natural Science Foundation of China
  • the Young Elite Scientists Sponsorship Program by China Association for Science and Technology

Zitieren

APA

Song, T., Zhao, S., Luo, S., Chen, C., Liu, X., Wu, X., Sun, Z., Cao, J., Wang, Z., Wang, Y., Yu, B., Zhang, Z., Du, X., Li, X., Han, Z., Chen, H., Chen, F., Wang, L., Wang, H., …, & Ji, Y. (2024). SLC44A2 regulates vascular smooth muscle cell phenotypic switching and aortic aneurysm. Journal of Clinical Investigation. https://doi.org/10.1172/jci173690

Vancouver

Song T, Zhao S, Luo S, Chen C, Liu X, Wu X, et al. SLC44A2 regulates vascular smooth muscle cell phenotypic switching and aortic aneurysm. Journal of Clinical Investigation. 2024. doi:10.1172/jci173690

BibTeX
@article{Song2024,
  author = {Song, Tianyu and Zhao, Shuang and Luo, Shanshan and Chen, Chuansheng and Liu, Xingeng and Wu, Xiaoqi and Sun, Zhongxu and Cao, Jiawei and Wang, Ziyu and Wang, Yineng and Yu, Bo and Zhang, Zhiren and Du, Xiaolong and Li, Xiaoqiang and Han, Zhijian and Chen, Hongshan and Chen, Feng and Wang, Liansheng and Wang, Hong and Sun, Kangyun and Han, Yi and Xie, Liping and Ji, Yong},
  title = {SLC44A2 regulates vascular smooth muscle cell phenotypic switching and aortic aneurysm},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci173690}
}
Kostenlos starten →